Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Gains from Investment Securities: 2010-2025

Historic Gains from Investment Securities for Exponent (EXPO) over the last 13 years, with Jan 2025 value amounting to $379,029.

  • Exponent's Gains from Investment Securities fell 38.70% to $4.2 million in Q2 2025 from the same period last year, while for Apr 2025 it was $12.6 million, marking a year-over-year decrease of 57.57%. This contributed to the annual value of $379,029 for FY2025, which is 18.18% down from last year.
  • According to the latest figures from FY2025, Exponent's Gains from Investment Securities is $379,029, which was down 18.18% from $463,235 recorded in FY2023.
  • Exponent's 5-year Gains from Investment Securities high stood at $463,235 for FY2023, and its period low was $379,029 during FY2025.
  • Over the past 2 years, Exponent's median Gains from Investment Securities value was $421,132 (recorded in 2023), while the average stood at $421,132.
  • As far as peak fluctuations go, Exponent's Gains from Investment Securities plummeted by 36.81% in 2021, and later increased by 9.29% in 2022.
  • Exponent's Gains from Investment Securities (Yearly) stood at $418,394 in 2021, then dropped by 3.51% to $403,727 in 2021, then climbed by 9.29% to $441,227 in 2022, then grew by 4.99% to $463,235 in 2023, then fell by 18.18% to $379,029 in 2025.